The DOI matches its Crossref record.
Use of NT-proBNP in Routine Testing and Comparison to BNP
Open accessAbstract
Objectives: B-type natriuretic peptide (BNP) is a strong diagnostic predictor of left-ventricular (LV)-dysfunction. Recently, the aminoterminal portion of pro-BNP (NT-proBNP) has been introduced, which could be even more sensitive because of its longer half-life. The aim of this study was to evaluate the new marker NT-proBNP within a large, heterogeneous population of patients with suspected cardiovascular disease at risk of cardiovascular dysfunction and to compare it with the established diagnostic parameter BNP. Subjects and methods: NT-proBNP and BNP were measured in 339 hospitalised patients undergoing diagnostic angiography (median age 66 years, 244 male vs. 95 female). Results: Median values of NT-proBNP increased with worsening LV-dysfunction and higher NYHA class. The area under the receiver operator characteristics curve (AUC) of NT-proBNP for detecting severe systolic dysfunction or for detecting any systolic LV-dysfunction was 0.83 and 0.77, respectively. The latter improved (AUC=0.81) when patients with clinically relevant heart disease like valvular dysfunction were included, independent of the haemodynamic values. Compared to BNP, NT-proBNP tended to be more accurate in identifying lesser degrees of LV-dysfunction. Conclusions: Even after optimisation of target criteria, there was still a substantial overlap of NT-proBNP values between patients with and without relevant heart disease. Therefore, NT-proBNP is not suitable as a screening test for LV-dysfunction in the community. Nevertheless, because of its good negative predictive value, NT-proBNP could be an easy and effective tool to rule out severe systolic LV-dysfunction in high risk patients. No clinically significant advantage of BNP testing could be found.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Heart Failure: Diagnosis, Management and Utilization
Inamdar, A., & Inamdar, A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5070062 · Cited by 412
Cao, Z., Jia, Y., & Zhu, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081820 · Cited by 398
Costello-Boerrigter, L. C., Boerrigter, G., Redfield, M. M., Rodeheffer, R. J., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., Heublein, D. M., & Burnett, J. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.025 · Cited by 369
NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope
Pfister, R., Hagemeister, J., Esser, S., Hellmich, M., Erdmann, E., & Schneider, C. A. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.013 · Cited by 35
Self-citation
Metadata
- Authors
- Pfister, R., Scholz, M., Wielckens, K., Erdmann, E., & Schneider, C. A.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-01
- Volume
- 6
- Issue
- 3
- Pages
- 289-293
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2051460799
- Cited by
- 165
- References
- 0
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of NT-proBNP in Routine Testing and Comparison to BNP. https://app.cochat.ai/papers/10.1016/j.ejheart.2003.12.012
- The paper
- Pfister, R., Scholz, M., Wielckens, K., Erdmann, E., & Schneider, C. A. (2004). Use of NT-proBNP in Routine Testing and Comparison to BNP. European Journal of Heart Failure. https://doi.org/10.1016/j.ejheart.2003.12.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.